Kiniksa Pharmaceuticals International Income Statement (2021-2025) | KNSA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 12.10M18.75M32.19M26.97M99.14M-148.30M48.34M71.47M67.05M83.39M79.86M108.63M112.21M122.54M137.78M156.80M180.85M
Cost of Revenue 2.77M3.87M4.22M5.03M6.94M6.71M0.49M7.70M9.09M9.58M10.58M12.32M20.11M17.90M17.87M18.60M20.26M
Gross Profit 9.33M14.88M27.97M21.94M92.20M-155.01M47.85M63.77M57.96M73.81M69.28M96.31M92.11M104.64M119.92M138.19M160.60M
Operating items
Research & Development 28.68M23.95M19.24M27.43M20.82M13.80M16.48M14.39M15.17M23.77M17.11M20.05M26.33M24.02M26.06M35.22M19.32M18.75M24.17M
Selling, General & Administrative 20.60M21.85M20.76M22.74M22.22M23.84M24.68M27.21M29.05M29.18M34.47M36.74M38.68M42.40M46.40M40.53M43.53M46.86M49.10M
Other Operating Expenses 2.47M2.77M4.70M12.47M8.70M11.56M14.23M15.32M21.68M26.40M26.52M31.38M42.34M49.42M66.08M61.66M71.02M83.56M
Operating Expenses 49.28M48.26M42.76M54.88M55.51M46.34M52.72M55.84M59.54M74.63M77.97M83.31M96.40M108.75M121.87M141.84M124.51M136.64M156.83M
Operating Income -49.28M-40.55M-30.67M-36.13M-23.32M-19.37M46.41M6.05M-11.20M-3.15M-10.93M0.08M-16.54M-0.12M-9.66M-19.30M13.27M20.16M24.02M
EBIT -49.28M-40.55M-30.67M-36.13M-23.32M-19.37M46.41M6.05M-11.20M-3.15M-10.93M0.08M-16.54M-0.12M-9.66M-19.30M13.27M20.16M24.02M
Non-operating items
Interest & Investment Income 0.01M0.01M0.01M0.08M0.03M0.10M0.32M
Other Non Operating Income 0.03M0.10M0.32M0.79M1.83M1.92M2.43M2.37M2.27M2.42M2.46M2.32M2.29M2.72M3.14M
Net income details
EBT -49.27M-40.55M-30.66M-43.80M-23.29M-19.27M46.73M90.91M-9.36M-1.24M-8.50M-72.03M-14.28M2.30M-7.20M-16.98M15.56M22.88M27.16M
Tax Provisions 0.21M1.01M-0.12M0.28M1.93M0.72M-177.36M2.38M2.91M-16.21M5.36M-22.79M3.43M6.21M5.49M-8.09M7.03M5.04M8.72M
Profit After Tax -49.48M-41.56M-30.54M-36.33M-25.21M-19.98M224.09M4.46M-12.27M14.97M-13.86M25.24M-17.70M-3.91M-12.69M-8.89M8.54M17.83M18.43M
Income from Continuing Operations -49.48M-41.56M-30.54M-44.08M-25.21M-19.98M224.09M88.53M-12.27M14.97M-13.86M-49.24M-17.70M-3.91M-12.69M-8.89M8.54M17.83M18.43M
Consolidated Net Income -49.48M-41.56M-30.54M-44.08M-25.21M-19.98M224.09M88.53M-12.27M14.97M-13.86M-49.24M-17.70M-3.91M-12.69M-8.89M8.54M17.83M18.43M
Income towards Parent Company -49.48M-41.56M-30.54M-44.08M-25.21M-19.98M224.09M88.53M-12.27M14.97M-13.86M-49.24M-17.70M-3.91M-12.69M-8.89M8.54M17.83M18.43M
Net Income towards Common Stockholders -49.48M-41.56M-30.54M-44.08M-25.21M-19.98M224.09M88.53M-12.27M14.97M-13.86M-49.24M-17.70M-3.91M-12.69M-8.89M8.54M17.83M18.43M
Additional items
EPS (Basic) -0.72-0.61-0.44-0.52-0.36-0.293.230.06-0.180.21-0.200.36-0.25-0.06-0.18-0.120.120.240.25
EPS (Weighted Average and Diluted) -0.72-0.61-0.44-0.52-0.36-0.293.180.05-0.180.21-0.200.36-0.25-0.06-0.18-0.120.110.230.23
Shares Outstanding (Weighted Average) 68.23M68.52M68.52M68.89M69.10M69.28M69.47M69.53M69.90M69.90M70.17M70.34M70.62M70.94M71.24M72.20M72.64M72.97M74.11M
Shares Outstanding (Diluted Average) 68.27M68.40M68.66M68.58M69.14M69.29M70.55M70.42M69.75M71.63M70.19M71.92M70.63M71.00M71.73M71.42M76.15M77.94M80.04M
EBITDA -49.47M-41.52M-30.62M-36.35M-25.25M-19.97M224.11M4.58M-12.26M14.93M-13.87M25.24M-17.76M-3.98M-12.60M-9.01M8.54M17.94M18.33M
Tax Rate 0.38%2.62%31.63%47.65%45.14%22.05%32.12%